瑞士诺华的地拉罗司是一种什么药物呢

What kind of drug is Switzerland's Novartis? Deferasirox is developed by Novartis and is currently the only oral iron chelator. Iron chelator is a new type of iron removal treatment based on directional binding with iron ions in the body, effectively increasing iron excretion, reducing iron content in the body and its pathological deposition in various organs. It is also the only effective drug currently used to treat iron overload.

The application of iron chelators has greatly reduced the mortality rate and improved the quality of life of patients with long-term blood transfusions. In 2005, the FDA approved the marketing of deferasirox. In 2010, deferasirox was approved in my country for use in children and adult patients over two years old who have iron accumulation due to the need for long-term blood transfusions (such as those with thalassemia or other rare anemias).

Let’s learn more about Novartis Pharmaceuticals. Novartis is one of the world's three largest pharmaceutical companies. In 1997, Novartis' China headquarters was established. At present, Novartis has grown from a company with only pharmaceutical business to a leader in the diversified pharmaceutical and health industry covering innovative patented drugs, eye care, generic drugs, consumer health care, vaccines and diagnostics.

Deferasirox from Swiss Novartis can remove free iron and intracellular iron, and prevent myocardial cells from taking up iron. It directly removes excess iron from myocardial cells, causing a continuous reduction in non-transferrin in the plasma. It is a first-line drug for patients with chronic iron overload caused by blood transfusion. Deferasirox's excellent iron-removing effectiveness, safety and patient compliance have greatly reduced the mortality of patients with diseases such as thalassemia and MDS that require long-term blood transfusion treatment, and improved their quality of life.

It should be noted that it cannot be taken with aluminum-containing antacids and cannot be combined with other iron chelation treatments. If patients need to use other drugs at the same time, they need to consult their doctor in advance.

Recommended related hot articles: /newsDetail/94044.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.